BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28378638)

  • 21. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PBEF1/NAmPRTase/Visfatin: a potential malignant astrocytoma/glioblastoma serum marker with prognostic value.
    Reddy PS; Umesh S; Thota B; Tandon A; Pandey P; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Rao MR; Kondaiah P; Somasundaram K
    Cancer Biol Ther; 2008 May; 7(5):663-8. PubMed ID: 18728403
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma.
    Zhang JQ; Yao QH; Kuang YQ; Ma Y; Yang LB; Huang HD; Cheng JM; Yang T; Liu EY; Liang L; Fan KX; Zhao K; Xia X; Gu JW
    Hum Pathol; 2014 Oct; 45(10):2154-61. PubMed ID: 25033730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between polymorphisms of XRCC5 genes with astrocytoma prognosis in the Han Chinese population.
    He X; Zhu X; Li L; Zhang J; Wu R; Zhang Y; Kang L; Yuan D; Jin T
    Oncotarget; 2016 Dec; 7(51):85283-85290. PubMed ID: 27852033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations.
    Reinhardt A; Stichel D; Schrimpf D; Sahm F; Korshunov A; Reuss DE; Koelsche C; Huang K; Wefers AK; Hovestadt V; Sill M; Gramatzki D; Felsberg J; Reifenberger G; Koch A; Thomale UW; Becker A; Hans VH; Prinz M; Staszewski O; Acker T; Dohmen H; Hartmann C; Mueller W; Tuffaha MSA; Paulus W; Heß K; Brokinkel B; Schittenhelm J; Monoranu CM; Kessler AF; Loehr M; Buslei R; Deckert M; Mawrin C; Kohlhof P; Hewer E; Olar A; Rodriguez FJ; Giannini C; NageswaraRao AA; Tabori U; Nunes NM; Weller M; Pohl U; Jaunmuktane Z; Brandner S; Unterberg A; Hänggi D; Platten M; Pfister SM; Wick W; Herold-Mende C; Jones DTW; von Deimling A; Capper D
    Acta Neuropathol; 2018 Aug; 136(2):273-291. PubMed ID: 29564591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of DNA-repair genes Ercc1 and Mgmt enhances temozolomide efficacy in gliomas treatment: a pre-clinical study.
    Boccard SG; Marand SV; Geraci S; Pycroft L; Berger FR; Pelletier LA
    Oncotarget; 2015 Oct; 6(30):29456-68. PubMed ID: 26336131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minichromosome maintenance protein 3 elicits a cancer-restricted immune response in patients with brain malignancies and is a strong independent predictor of survival in patients with anaplastic astrocytoma.
    Söling A; Sackewitz M; Volkmar M; Schaarschmidt D; Jacob R; Holzhausen HJ; Rainov NG
    Clin Cancer Res; 2005 Jan; 11(1):249-58. PubMed ID: 15671553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exonuclease 1 (Exo1) Participates in Mammalian Non-Homologous End Joining and Contributes to Drug Resistance in Ovarian Cancer.
    He D; Li T; Sheng M; Yang B
    Med Sci Monit; 2020 Mar; 26():e918751. PubMed ID: 32167078
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EXO1 is critical for embryogenesis and the DNA damage response in mice with a hypomorphic Nbs1 allele.
    Rein K; Yanez DA; Terré B; Palenzuela L; Aivio S; Wei K; Edelmann W; Stark JM; Stracker TH
    Nucleic Acids Res; 2015 Sep; 43(15):7371-87. PubMed ID: 26160886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Geminin: a good prognostic factor in high-grade astrocytic brain tumors.
    Shrestha P; Saito T; Hama S; Arifin MT; Kajiwara Y; Yamasaki F; Hidaka T; Sugiyama K; Kurisu K
    Cancer; 2007 Mar; 109(5):949-56. PubMed ID: 17262828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platform-Independent Genome-Wide Pattern of DNA Copy-Number Alterations Predicting Astrocytoma Survival and Response to Treatment Revealed by the GSVD Formulated as a Comparative Spectral Decomposition.
    Aiello KA; Alter O
    PLoS One; 2016; 11(10):e0164546. PubMed ID: 27798635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.
    Jones DT; Mulholland SA; Pearson DM; Malley DS; Openshaw SW; Lambert SR; Liu L; Bäcklund LM; Ichimura K; Collins VP
    Acta Neuropathol; 2011 Jun; 121(6):753-61. PubMed ID: 21327941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.
    Guan Y; Mizoguchi M; Yoshimoto K; Hata N; Shono T; Suzuki SO; Araki Y; Kuga D; Nakamizo A; Amano T; Ma X; Hayashi K; Sasaki T
    Clin Cancer Res; 2010 Aug; 16(16):4289-97. PubMed ID: 20601442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use of Three Long Non-Coding RNAs as Potential Prognostic Indicators of Astrocytoma.
    Zhi F; Wang Q; Xue L; Shao N; Wang R; Deng D; Wang S; Xia X; Yang Y
    PLoS One; 2015; 10(8):e0135242. PubMed ID: 26252651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
    Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
    Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.
    Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
    Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated expression of HSP10 protein inhibits apoptosis and associates with poor prognosis of astrocytoma.
    Fan W; Fan SS; Feng J; Xiao D; Fan S; Luo J
    PLoS One; 2017; 12(10):e0185563. PubMed ID: 29028811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exonuclease 1 and its versatile roles in DNA repair.
    Keijzers G; Liu D; Rasmussen LJ
    Crit Rev Biochem Mol Biol; 2016; 51(6):440-451. PubMed ID: 27494243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA repair genes in astrocytoma tumorigenesis, progression and therapy resistance.
    Sousa JF; Serafim RB; Freitas LM; Fontana CR; Valente V
    Genet Mol Biol; 2019; 43(1 suppl 1):e20190066. PubMed ID: 31930277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.